HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ME1071

a metallo-beta-lactamase inhibitor that can aid in treatment of ventilator-associated pneumonia

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Dicarboxylic Acids: 108
      - Maleates: 3
        ME1071: 1

Experts

1.	Harada, Yosuke: 1 article (09/2013)
2.	Hasegawa, Hiroo: 1 article (09/2013)
3.	Imamura, Yoshifumi: 1 article (09/2013)
4.	Izumikawa, Koichi: 1 article (09/2013)
5.	Kakeya, Hiroshi: 1 article (09/2013)
6.	Kaku, Norihito: 1 article (09/2013)
7.	Kohno, Shigeru: 1 article (09/2013)
8.	Migiyama, Yohei: 1 article (09/2013)
9.	Miyazaki, Taiga: 1 article (09/2013)
10.	Morinaga, Yoshitomo: 1 article (09/2013)

Related Diseases

1.	Ventilator-Associated Pneumonia 09/01/2013 - "To confirm the clinical efficacy of ME1071 in ventilator-associated pneumonia (VAP) caused by MBL-producing P. " 09/01/2013 - "In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa."

Related Drugs and Biologics

1.	biapenem (L 627)